Your browser doesn't support javascript.
loading
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
Shanmugasundaram, Krithika; Goyal, Subir; Switchenko, Jeffery; Calzada, Oscar; Churnetski, Michael C; Kolla, Bhaskar; Bachanova, Veronika; Gerson, James N; Barta, Stefan K; Gordon, Max J; Danilov, Alexey V; Grover, Natalie S; Mathews, Stephanie; Burkart, Madelyn; Karmali, Reem; Sawalha, Yazeed; Hill, Brian T; Ghosh, Nilanjan; Park, Steven I; Epperla, Narendranath; Bond, David A; Badar, Talha; Blum, Kristie A; Hamadani, Mehdi; Fenske, Timothy S; Malecek, Mary; Kahl, Brad S; Martin, Peter; Guo, Jin; Flowers, Christopher R; Cohen, Jonathon B.
Afiliación
  • Shanmugasundaram K; National Institutes of Health, National Cancer Institute, Bethesda, MD, US.
  • Goyal S; Winship Cancer Institute, Biostatistics and Bioinformatics, Emory University, Atlanta, GA, US.
  • Switchenko J; Winship Cancer Institute, Biostatistics and Bioinformatics, Emory University, Atlanta, GA, US.
  • Calzada O; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University Hospital, Atlanta, GA, US.
  • Churnetski MC; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University Hospital, Atlanta, GA, US.
  • Kolla B; Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN, US.
  • Bachanova V; Division of Hematology Oncology and Transplantation, University of Minnesota, Minneapolis, MN, US.
  • Gerson JN; Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, US.
  • Barta SK; Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, US.
  • Gordon MJ; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, US.
  • Danilov AV; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, US.
  • Grover NS; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, US.
  • Mathews S; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, US.
  • Burkart M; Division of Hematology, Northwestern University, Chicago, IL, US.
  • Karmali R; Division of Hematology, Northwestern University, Chicago, IL, US.
  • Sawalha Y; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, US.
  • Hill BT; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH, US.
  • Ghosh N; Levine Cancer Institute, Charlotte, NC, US.
  • Park SI; Levine Cancer Institute, Charlotte, NC, US.
  • Epperla N; Division of Hematology, The Ohio State University Cancer Center, Columbus, OH, US.
  • Bond DA; Mayo Clinic, Jacksonville, FL, US.
  • Badar T; Division of Hematology, The Ohio State University Cancer Center, Columbus, OH, US.
  • Blum KA; Mayo Clinic, Jacksonville, FL, US.
  • Hamadani M; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University Hospital, Atlanta, GA, US.
  • Fenske TS; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, US.
  • Malecek M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, US.
  • Kahl BS; Siteman Cancer Center, Washington University, St. Louis, MO, US.
  • Martin P; Siteman Cancer Center, Washington University, St. Louis, MO, US.
  • Guo J; Weill Cornell Medicine, New York, NY, US.
  • Flowers CR; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
  • Cohen JB; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Eur J Haematol ; 107(3): 301-310, 2021 Sep.
Article en En | MEDLINE | ID: mdl-33973276
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Linfoma de Células del Manto / Citarabina Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Linfoma de Células del Manto / Citarabina Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido